发明授权
- 专利标题: Imidazo[1,2-A]pyridine compounds as VEGF-R2 inhibitors
- 专利标题(中): 咪唑并[1,2-A]吡啶化合物作为VEGF-R2抑制剂
-
申请号: US11816416申请日: 2006-02-23
-
公开(公告)号: US07666879B2公开(公告)日: 2010-02-23
- 发明人: David Anthony Barda , Timothy Paul Burkholder , Joshua Ryan Clayton , Yan Hao , James Robert Henry , John Monte Knobeloch , Johnathan Alexander McLean , David Mendel , Mark Edward Rempala , Zhao-Qing Wang , Yvonne Yee Mai Yip , Boyu Zhong
- 申请人: David Anthony Barda , Timothy Paul Burkholder , Joshua Ryan Clayton , Yan Hao , James Robert Henry , John Monte Knobeloch , Johnathan Alexander McLean , David Mendel , Mark Edward Rempala , Zhao-Qing Wang , Yvonne Yee Mai Yip , Boyu Zhong
- 申请人地址: US IN Indianapolis
- 专利权人: Eli Lilly and Company
- 当前专利权人: Eli Lilly and Company
- 当前专利权人地址: US IN Indianapolis
- 代理商 Elizabeth A. McGraw; Tina M. Tucker
- 国际申请: PCT/US2006/006283 WO 20060223
- 国际公布: WO2006/091671 WO 20060831
- 主分类号: A01N43/42
- IPC分类号: A01N43/42 ; A61K31/44 ; C07D471/02 ; C07D491/02 ; C07D498/02 ; C07D513/02 ; C07D515/02 ; C07D401/00
摘要:
The present invention provides compounds that are inhibitors of VEGF-R2 of the formula: (I) and methods of using these compounds.
公开/授权文献
- US20090227622A1 IMIDAZO[1,2-A]PYRIDINE COMPOUNDS AS VEGF-R2 INHIBITORS 公开/授权日:2009-09-10